Literature DB >> 16707626

A tail of two signals: the C terminus of the A(2A)-adenosine receptor recruits alternative signaling pathways.

Ingrid Gsandtner1, Michael Freissmuth.   

Abstract

G protein-coupled receptors are endowed with carboxyl termini that vary greatly in length and sequence. In most instances, the distal portion of the C terminus is dispensable for G protein coupling. This is also true for the A(2A)-adenosine receptor, where the last 100 amino acids are of very modest relevance to G(s) coupling. The C terminus was originally viewed mainly as the docking site for regulatory proteins of the beta-arrestin family. These beta-arrestins bind to residues that have been phosphorylated by specialized kinases (G protein-coupled receptor kinases) and thereby initiate receptor desensitization and endocytosis. More recently, it has become clear that many additional "accessory" proteins bind to C termini of G protein-coupled receptors. The article by Sun et al. in the current issue of Molecular Pharmacology identifies translin-associated protein-X as yet another interaction partner of the A(2A) receptor; translin-associated protein allows the A(2A) receptor to impinge on the signaling mechanisms by which p53 regulates neuronal differentiation, but the underlying signaling pathways are uncharted territory. With a list of five known interaction partners, the C terminus of the A(2A) receptor becomes a crowded place. Hence, there must be rules that regulate the interaction. This allows the C terminus to act as coincidence detector and as signal integrator. Despite our ignorance about the precise mechanisms, the article has exciting implications: the gene encoding for translin-associated protein-X maps to a locus implicated in some forms of schizophrenia; A(2A) receptor agonists are candidate drugs for the treatment of schizophrenic symptoms. It is of obvious interest to explore a possible link.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16707626     DOI: 10.1124/mol.106.026757

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  7 in total

Review 1.  The A(2A)-adenosine receptor: a GPCR with unique features?

Authors:  J Zezula; M Freissmuth
Journal:  Br J Pharmacol       Date:  2008-02-04       Impact factor: 8.739

2.  Internalization and desensitization of adenosine receptors.

Authors:  Elisabeth C Klaasse; Adriaan P Ijzerman; Willem J de Grip; Margot W Beukers
Journal:  Purinergic Signal       Date:  2007-11-13       Impact factor: 3.765

Review 3.  Structure-function studies with G protein-coupled receptors as a paradigm for improving drug discovery and development of therapeutics.

Authors:  Patrick M McNeely; Andrea N Naranjo; Anne S Robinson
Journal:  Biotechnol J       Date:  2012-12       Impact factor: 4.677

4.  Binding of the Antagonist Caffeine to the Human Adenosine Receptor hA2AR in Nearly Physiological Conditions.

Authors:  Ruyin Cao; Giulia Rossetti; Andreas Bauer; Paolo CarIoni
Journal:  PLoS One       Date:  2015-05-20       Impact factor: 3.240

5.  The Specificity of Downstream Signaling for A1 and A2AR Does Not Depend on the C-Terminus, Despite the Importance of This Domain in Downstream Signaling Strength.

Authors:  Abhinav R Jain; Claire McGraw; Anne S Robinson
Journal:  Biomedicines       Date:  2020-12-13

6.  Reengineering the collision coupling and diffusion mode of the A2A-adenosine receptor: palmitoylation in helix 8 relieves confinement.

Authors:  Simon Keuerleber; Patrick Thurner; Christian W Gruber; Jürgen Zezula; Michael Freissmuth
Journal:  J Biol Chem       Date:  2012-10-15       Impact factor: 5.157

7.  Recruitment of a cytoplasmic chaperone relay by the A2A adenosine receptor.

Authors:  Christian Bergmayr; Patrick Thurner; Simon Keuerleber; Oliver Kudlacek; Christian Nanoff; Michael Freissmuth; Christian W Gruber
Journal:  J Biol Chem       Date:  2013-08-21       Impact factor: 5.157

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.